- Home
- RFI vs TCMD Comparison
RFI vs TCMD Comparison
Compare RFI & TCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RFI
- TCMD
- Stock Information
- Founded
- RFI 1992
- TCMD 1995
- Country
- RFI United States
- TCMD United States
- Employees
- RFI N/A
- TCMD N/A
- Industry
- RFI Investment Managers
- TCMD Medical/Dental Instruments
- Sector
- RFI Finance
- TCMD Health Care
- Exchange
- RFI Nasdaq
- TCMD Nasdaq
- Market Cap
- RFI 344.7M
- TCMD 344.2M
- IPO Year
- RFI N/A
- TCMD 2016
- Fundamental
- Price
- RFI $12.73
- TCMD $14.50
- Analyst Decision
- RFI
- TCMD
- Analyst Count
- RFI 0
- TCMD 0
- Target Price
- RFI N/A
- TCMD N/A
- AVG Volume (30 Days)
- RFI 69.8K
- TCMD 134.5K
- Earning Date
- RFI 01-01-0001
- TCMD 11-04-2024
- Dividend Yield
- RFI 8.25%
- TCMD N/A
- EPS Growth
- RFI N/A
- TCMD 9789.88
- EPS
- RFI N/A
- TCMD 1.36
- Revenue
- RFI N/A
- TCMD $281,544,000.00
- Revenue This Year
- RFI N/A
- TCMD $9.66
- Revenue Next Year
- RFI N/A
- TCMD $11.09
- P/E Ratio
- RFI N/A
- TCMD $10.61
- Revenue Growth
- RFI N/A
- TCMD 5.71
- 52 Week Low
- RFI $9.62
- TCMD $9.70
- 52 Week High
- RFI $12.52
- TCMD $16.95
- Technical
- Relative Strength Index (RSI)
- RFI 44.70
- TCMD 57.17
- Support Level
- RFI $12.88
- TCMD $14.18
- Resistance Level
- RFI $13.14
- TCMD $14.73
- Average True Range (ATR)
- RFI 0.17
- TCMD 0.37
- MACD
- RFI -0.02
- TCMD -0.01
- Stochastic Oscillator
- RFI 21.74
- TCMD 77.88
About RFI Cohen & Steers Total Return Realty Fund Inc.
Cohen & Steers Total Return Realty Fund Inc is a diversified, closed-end management investment company. Its investment objective is to achieve a high total return through investment in real estate securities. The Fund invests majority of its total assets in the equity securities of real estate companies under normal circumstances, which includes common shares, REITs, rights or warrants, convertible securities, and preferred shares.
About TCMD Tactile Systems Technology Inc.
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.